OAK

0.00%

6.7¢ oakridge international limited

Removal of a Director by members, page-245

First 245 Last

Share
Profile

Follow
elit

13,316 Posts.

168

19/05/17

04:09

Post #: 24783546
Share

Originally posted by elit ↑

Growler you have mail.

In short, I changes to the board are required as from Governance perspective there appears to be a big gap with the lack of independent experienced directors and shown to be an issue imo in view of past events that have transpired. Athan for his big salary, past track record and lack of proof that can deliver commercialisation opportunities that is current focus (not sure right skill set at this juncture) means he gives shareholder no choice imo but to seek his removal. I would like to believe more in his ability to execute their strategy but given nothing so to seek his removal becomes a necessity imo as messages about addressing Governance issues and improved reporting to shareholders on state of various activities not getting through.

I also believe John Schultz should be removed as having both Chris and John on the board means we suffer from lack of experienced Directors with relevant Corporate and Director Experience. John fulfils an important management role but should step down or be removed as director as carrying too many green and inexperienced directors.

I am concerned they have pursued an overaggressive expansion/acquisition strategy when would be better focussed on current capabilities and opportunities. Start ups need to be frugal and run on oily rags but they have built up excessive cash burn at this stage of development with next to no revenues, but huge executive salaries (red flag), acquisitions that have required some decent upfront cash (moreso for JCT) and added to already large cash burn with more staff costs and investment in JCT inventory. They seem to have overextended themselves and spread their attentions to thin which is reflected in not one new dollar of revenue flowing through since their backdoor entry via RYG.

They might have justified more their strategy if they were more forthcoming in communicating with shareholders and updating them on their plans but got bugger all for last six months and/or any explanations for many missed milestones. How can I support a company that delivers no revenue or seeks to reaffirm confidence they can succeed when just continuing to add to ever growing cash outflows with yet another acquisition that is some time away from being cash flow positive.

I just don't understand their communication strategy when they keep wanting to ask for shareholder funds to justify their aggressive expansion plans but not updating as on state of play for such investments like JCT.

I am pretty appalled at the lack of proper management communication and even more appalled that the one man Cadman advisor put as their front man for investor relations who refuses to communicate or answer any shareholder queries. I won't even start on his role as advisor for XPED or how appointed.

I think the tech is good, and Marty is good acquisition, but to move forward need a clean up of the board and governance issues to ensure shareholders best interests are protected.

Expand

Hey growler how many shares do you have counted in support of removal of lekkas now?

XPE Price at posting: 1.3¢ Sentiment: Sell Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 136 more messages in this thread...

First 245 Last

Add OAK (ASX) to my watchlist

(20min delay)
Last 6.7¢		Change 0.000(0.00%)		Mkt cap ! $1.808M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	380	6.7¢

Sellers (Offers)

Price($)	Vol.	No.
9.9¢	65728	1

View Market Depth

No.	Vol.	Price($)
3	380	0.067
1	34272	0.062
1	20100	0.061
1	82000	0.060
1	55000	0.053

Price($)	Vol.	No.
0.099	65728	1
0.105	1524	1
0.175	22450	1
0.180	30000	1
0.190	29137	1

Last trade - 16.12pm 04/10/2024 (20 minute delay)

OAK (ASX) Chart

Day chart unavailable

Removal of a Director by members, page-245

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Removal of a Director by members, page-245

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News